|
Genetic Determinants of Sudden Cardiac Death Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Genetic Determinants of Sudden Cardiac Death conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Genetic Determinants of Sudden Cardiac Death Clinical research trials and Genetic Determinants of Sudden Cardiac Death healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Genetic Determinants of Sudden Cardiac Death. Genetic Determinants of Sudden Cardiac Death Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Genetic Determinants of Sudden Cardiac Death clinical trial. Participants typically obtain the most effective healthcare available for their Genetic Determinants of Sudden Cardiac Death condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "G" Clinical Trials Conditions > Genetic Determinants of Sudden Cardiac Death  Genetic Determinants of Sudden Cardiac Death
Genetic Determinants of Sudden Cardiac Death
For Condition: Ventricular Arrhythmia,Heart Diseases,Arrhythmia,Cardiovascular Diseases,Death, Sudden, Cardiac
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To evaluate whether sequence variants and selected cardiac ion channel genes are associated with risk of sudden cardiac death in the general population.
Details: BACKGROUND: Sudden cardiac death (SCD) affects 400,000 individuals each year in the U.S. alone. Over half have no evidence of heart disease prior to death, and the ability to identify those at risk and therefore prevent SCD is poor. Mutations in cardiac ion channel genes including SCN5A, KVLQT1, HERG, KCNE1, KCNE2, and RyR2 have been implicated in monogenic traits with a high risk of SCD, such as the long-QT, Brugada, sudden infant death syndrome, and catecholaminergic polymorphic ventricular tachycardia. Alterations in ion channel function can result in life-threatening ventricular arrhythmias in diverse disease states. Therefore, sequence variants in these genes that alter function or transcription of these ion channels may confer a predisposition to ventricular arrhythmia and SCD in broader populations. DESIGN NARRATIVE: This study will determine if sequence variants in the cardiac ion channel genes are associated with an increased risk of sudden cardiac death in apparently healthy populations. Cases of sudden cardiac death will be assembled from five NIH-funded prospective cohorts with a total of 106,314 individuals with existent blood samples. All cohorts are exceptionally well characterized with respect to environmental exposures and have collected medical records on cardiovascular endpoints. The investigators will characterize all coding sequence variation and selected non-coding sequence variation among 100 cases and controls from these cohorts. Using these novel markers, they will define the haplotype block structure (SNPs in linkage disequilibrium) for the six cardiac ion channel genes, including SCN5A, KVLQT1, HERG, KCNE1, KCNE2, and RyR2. They will then employ a nested case-control design and conditional logistic regression to test for associations between haplotypes (haplotype tag SNPs) in both coding and non-coding regions and sudden cardiac death risk. They will also test directly for associations between single loci that may have functional significance and sudden cardiac death risk. An estimated 600 cases of well-documented sudden cardiac death will be confirmed over the first three years of the grant period, and these cases will be matched on age, sex, ethnicity, and geographic location to two control subjects from the same cohort. In addition, based upon known sex-differences in the phenotypic expression of the candidate genes in the primary arrhythmic disorders, the investigators will specifically examine sex-differences in the risk of sudden cardiac death associated with sequence variation in these genes. The findings generated will have substantial implications for our understanding of the sudden cardiac death syndrome and risk stratification in the general population.
Eligibility:
Study Type: Observational, Natural History, Case Control
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Overall Study Official:
ChristineAlbert, , Brigham and Women's Hospital
Additional Information:
Study ID Numbers: 1228;
Study Start Date: July 2003
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00064558
Other Ventricular Arrhythmia Studies:
1. Cardiovascular Risk Factors in United States Adolescents and Adults
2. Lifestyle Heart Trial
3. Charleston Heart Study - Predictors of Coronary Disease in Blacks
4. Polyunsaturated Fats and Risk of Primary Cardiac Arrest
5. Epidemiological Tool To Detect Angina Pectoris in Blacks
Related Studies:
Other Ventricular Arrhythmia Clinical Trials
Other Clinical Trials
Other Clinical Trials
Genetic Determinants of Sudden Cardiac Death
|
|
|
|
|
|
|
|
